TNBC, accounting for 10-20% of all breast cancers, is characterized by its lack of expression of the progesterone receptor (PR), estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)5. This evidence concerns the gene ERBB2 and breast carcinoma.